Meeting
2020 Gastrointestinal Cancers Symposium
Utility of PET-CT CMR after neoadjuvant chemotherapy with DCF for esophageal cancer as a predictive factor of recurrence.
Authors
Suzuki Kosuke
Department of Gastroentenological and Pediatric Surgery, Oita University Faculty of Medicine, Oita, Japan
Suzuki Kosuke , Shibata Tomotaka , Nishiki Kohei , Fumoto Shoichi , Kono Kohei , Akagi Tomonori , Tojigamori Manabu , Ueda Yoshitake , Shiroshita Hidefumi , Etoh Tsuyoshi , Shiraishi Norio , Inomata Masafumi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 434)
Abstract #
434
Poster Bd #
H1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Safety and efficacy of prophylactic pegfilgrastim on day 3 of neoadjuvant DCF chemotherapy in elderly patients with resectable esophageal cancer.
First Author: Go Ikeda
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Efficacy of prophylactic pegfilgrastim on day three of preoperative DCF chemotherapy in elderly patients with resectable esophageal cancer.
First Author: Go Ikeda
Poster
2020 ASCO Virtual Scientific Program
Dissecting outcomes of patients (pts) with <ypT2N0 disease after neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC): Results from a large, international, multicenter collaboration.
First Author: Praful Ravi
Poster
2020 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy (TPF regimen) followed with robotic surgery and its impact on outcome in management of esophageal cancers: Indian experience.
First Author: S.P. Somashekhar